InsidersTradesSigma
基于 2 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
Discover the detailed record of transactions filed by Cloonan Michael. Insider active across 2 companies, notably bluebird bio, Inc.. Aggregated, 8 reports have been published. Split: 0 buy · 2 sells. Total volume traded: €623k. History available since 30 September 2024. The latest transaction was filed on 29 September 2025 (Cession). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 条申报中的 8 条
Cloonan Michael is linked to Sionna Therapeutics, Inc. as President & CEO and to bluebird bio, Inc. as Director. The record shows 5 filings in total, and across the 5 sampled filings from 2024-10-02 to 2025-09-30, buy volume is EUR 0 and sell volume is EUR 622874, with Levée d'options as the most frequent transaction nature.